Sanofi SA (EPA:SAN) has been given a €76.00 ($80.00) target price by equities researchers at JPMorgan Chase & Co. in a research note issued to investors on Monday. The firm currently has a “sell” rating on the stock.

Several other research firms have also issued reports on SAN. Kepler Capital Markets set a €89.00 ($93.68) price target on shares of Sanofi SA and gave the company a “buy” rating in a research report on Thursday, August 11th. Jefferies Group set a €76.00 ($80.00) price target on shares of Sanofi SA and gave the company a “neutral” rating in a research report on Tuesday, September 13th. Berenberg Bank set a €93.00 ($97.89) price target on shares of Sanofi SA and gave the company a “buy” rating in a research report on Thursday, September 8th. Societe Generale set a €100.00 ($105.26) price target on shares of Sanofi SA and gave the company a “buy” rating in a research report on Monday, August 1st. Finally, Deutsche Bank AG set a €95.00 ($100.00) price target on shares of Sanofi SA and gave the company a “buy” rating in a research report on Thursday, October 13th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of €84.00 ($88.42).

Analyst Recommendations for Sanofi SA (EPA:SAN)

Sanofi SA (EPA:SAN) opened at 76.32 on Monday. The company has a market cap of €98.22 billion and a P/E ratio of 23.42. The company has a 50-day moving average of €25.50 and a 200 day moving average of €25.74. Sanofi SA has a 52 week low of €62.50 and a 52 week high of €84.81.

ILLEGAL ACTIVITY WARNING: “Sanofi SA (SAN) PT Set at €76.00 by JPMorgan Chase & Co.” was posted by Daily Political and is owned by of Daily Political. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this report can be read at http://www.dailypolitical.com/2016/11/29/sanofi-sa-san-pt-set-at-76-00-by-jpmorgan-chase-co.html.

About Sanofi SA

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.

Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.